Literature DB >> 16146764

HIV disorders of the brain: pathology and pathogenesis.

Luis Del Valle1, Sergio Piña-Oviedo.   

Abstract

Infection with HIV-1 has spread exponentially in recent years to reach alarming proportions. It is estimated than more than 33 million adults and 1.3 million children are infected worldwide. Approximately 16,000 new cases are diagnosed every day and almost 3 million people die every year from AIDS, making it the fourth leading cause of death in the world. Since the introduction of highly active anti-retroviral therapy (HAART) in the mid 1990s, the morbidity and mortality associated with HIV-1 infection has significantly decreased and AIDS has become a chronic disorder. However, neuropathological conditions associated with AIDS are still present in approximately 70 to 90% of patients and can be the result of HIV itself or of opportunistic infections. Here we briefly review the pathology and pathophysiology of AIDS-Encephalopathy, of some of the significant opportunistic infections affecting the brain in the context of AIDS, including Progressive Multifocal Leukoencephalopathy (PML) a demyelinating disease caused by the human neurotropic JC virus, Toxoplasmosis, Cryptococcosis and of primary CNS lymphoma, a brain malignancy frequently associated with HIV-1 infection, all of them considered AIDS defining conditions.

Entities:  

Mesh:

Year:  2006        PMID: 16146764     DOI: 10.2741/1830

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  44 in total

1.  HIV-1 Tat protein promotes neuronal dysfunction through disruption of microRNAs.

Authors:  J Robert Chang; Ruma Mukerjee; Asen Bagashev; Luis Del Valle; Tinatin Chabrashvili; Brian J Hawkins; Johnny J He; Bassel E Sawaya
Journal:  J Biol Chem       Date:  2011-09-28       Impact factor: 5.157

Review 2.  Diagnostic assays for polyomavirus JC and progressive multifocal leukoencephalopathy.

Authors:  Martyn K White; Ilker K Sariyer; Jennifer Gordon; Serena Delbue; Valeria Pietropaolo; Joseph R Berger; Kamel Khalili
Journal:  Rev Med Virol       Date:  2015-12-14       Impact factor: 6.989

3.  Detection of human polyomavirus proteins, T-antigen and agnoprotein, in human tumor tissue arrays.

Authors:  Luis Del Valle; Kamel Khalili
Journal:  J Med Virol       Date:  2010-05       Impact factor: 2.327

4.  Alterations of DNA damage repair pathways resulting from JCV infection.

Authors:  Armine Darbinyan; Martyn K White; Selma Akan; Sujatha Radhakrishnan; Luis Del Valle; Shohreh Amini; Kamel Khalili
Journal:  Virology       Date:  2007-03-21       Impact factor: 3.616

5.  Progressive multifocal leukoencephalopathy: cavitary white matter lesions.

Authors:  Caroline Raasch Alquist; Robin McGoey; Luis Del Valle
Journal:  J La State Med Soc       Date:  2012 Nov-Dec

Review 6.  Animal Models for Progressive Multifocal Leukoencephalopathy.

Authors:  Martyn K White; Jennifer Gordon; Joseph R Berger; Kamel Khalili
Journal:  J Cell Physiol       Date:  2015-12       Impact factor: 6.384

7.  JC virus agnoprotein inhibits in vitro differentiation of oligodendrocytes and promotes apoptosis.

Authors:  Nana Merabova; Dorota Kaniowska; Rafal Kaminski; Satish L Deshmane; Martyn K White; Shohreh Amini; Armine Darbinyan; Kamel Khalili
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

8.  Novel expression of PINCH in the central nervous system and its potential as a biomarker for human immunodeficiency virus-associated neurodegeneration.

Authors:  Ann Rearden; Rosemary Hurford; Nhan Luu; Emily Kieu; Melissa Sandoval; Georgina Perez-Liz; Luis Del Valle; Henry Powell; T Dianne Langford
Journal:  J Neurosci Res       Date:  2008-08-15       Impact factor: 4.164

9.  Inhibition of SNAP25 expression by HIV-1 Tat involves the activity of mir-128a.

Authors:  Davide Eletto; Giuseppe Russo; Giovanni Passiatore; Luis Del Valle; Antonio Giordano; Kamel Khalili; Elisa Gualco; Francesca Peruzzi
Journal:  J Cell Physiol       Date:  2008-09       Impact factor: 6.384

10.  IGF-IR-dependent expression of Survivin is required for T-antigen-mediated protection from apoptosis and proliferation of neural progenitors.

Authors:  E Gualco; K Urbanska; G Perez-Liz; T Sweet; F Peruzzi; K Reiss; L Del Valle
Journal:  Cell Death Differ       Date:  2009-10-16       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.